TWD 22.35
(-1.76%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 264.65 Million TWD | -3.1% |
2022 | 273.11 Million TWD | 78.7% |
2021 | 152.83 Million TWD | -30.99% |
2020 | 221.47 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 280.6 Million TWD | 6.03% |
2023 FY | 264.65 Million TWD | -3.1% |
2023 Q4 | 264.65 Million TWD | -12.65% |
2023 Q2 | 302.99 Million TWD | 10.94% |
2022 Q4 | 273.11 Million TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 90.877% |
Level Biotechnology Inc. | 822.67 Million TWD | 67.83% |
Sagittarius Life Science Corp | 664.72 Million TWD | 60.185% |
NeoCore Technology Co., Ltd. | 548.74 Million TWD | 51.771% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 93.203% |
GlycoNex Incorporation | 1.55 Billion TWD | 82.956% |
VBI | 452.1 Million TWD | 41.461% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | 77.498% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 64.645% |
Visgeneer Inc. | 397.17 Million TWD | 33.365% |
Mycenax Biotech Inc. | 3.77 Billion TWD | 92.981% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 87.742% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 70.031% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 95.656% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -259.794% |
Enimmune corporation | 604.82 Million TWD | 56.243% |
TaiRx, Inc. | 833.74 Million TWD | 68.257% |
CHO Pharma, Inc. | 3.08 Billion TWD | 91.424% |
EirGenix Inc. | 11.16 Billion TWD | 97.629% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 53.823% |
Sunny Pharmtech Inc. | 1.71 Billion TWD | 84.544% |
Lin BioScience, Inc. | 3.59 Billion TWD | 92.642% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 74.806% |
Feng Chi Biotech Corp. | 301.03 Million TWD | 12.083% |
Lukas Biomedical Inc. | 441.19 Million TWD | 40.013% |
RBC Bioscience Corporation | 753.79 Million TWD | 64.89% |
BiOptic Inc. | 613.77 Million TWD | 56.88% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | 85.121% |
Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 77.179% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 58.958% |
Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 91.48% |
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -106.687% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | 30.052% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 76.658% |
Neith Corporation | 192.15 Million TWD | -37.732% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -78.902% |
NaviFUS Corp. | 490.53 Million TWD | 46.047% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 78.408% |
Sinew Pharma Inc. | 1.36 Billion TWD | 80.588% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 49.984% |
Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 77.212% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 84.021% |
AP Biosciences Inc | 890.75 Million TWD | 70.288% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 96.896% |
3D Global Biotech Inc. | 324.14 Million TWD | 18.353% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | 80.155% |
Intech Biopharm Corporation | 2.71 Billion TWD | 90.238% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 98.277% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 35.49% |
TWi Biotechnology, Inc. | 396.85 Million TWD | 33.311% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 87.251% |
TCI GENE Inc. | 1.16 Billion TWD | 77.301% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | 10.158% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | 80.587% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 71.898% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 62.108% |
PharmaEngine, Inc. | 3.95 Billion TWD | 93.306% |
Savior Lifetec Corporation | 3.82 Billion TWD | 93.077% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 78.48% |
OBI Pharma, Inc. | 5.6 Billion TWD | 95.277% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | 75.08% |
Acepodia, Inc. | 6.81 Billion TWD | 96.119% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 93.084% |